These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 23124163

  • 21. Design, Synthesis and Antibacterial Activities of Novel Amide Derivatives Bearing Dioxygenated Rings as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y, Liang YQ, Wang XY, Chang HY, Hu SP, Sun J.
    Chem Pharm Bull (Tokyo); 2022; 70(8):544-549. PubMed ID: 35908920
    [Abstract] [Full Text] [Related]

  • 22. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
    Segretti ND, Serafim RA, Segretti MC, Miyata M, Coelho FR, Augusto O, Ferreira EI.
    Bioorg Med Chem Lett; 2016 Aug 15; 26(16):3988-93. PubMed ID: 27426865
    [Abstract] [Full Text] [Related]

  • 23. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S.
    J Med Chem; 2005 Mar 10; 48(5):1596-609. PubMed ID: 15743201
    [Abstract] [Full Text] [Related]

  • 24. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies.
    Ramamoorthy D, Turos E, Guida WC.
    J Chem Inf Model; 2013 May 24; 53(5):1138-56. PubMed ID: 23581389
    [Abstract] [Full Text] [Related]

  • 25. Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Yang YS, Zhang F, Gao C, Zhang YB, Wang XL, Tang JF, Sun J, Gong HB, Zhu HL.
    Bioorg Med Chem Lett; 2012 Jul 15; 22(14):4619-24. PubMed ID: 22721711
    [Abstract] [Full Text] [Related]

  • 26. Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents.
    Zhang HJ, Zhu DD, Li ZL, Sun J, Zhu HL.
    Bioorg Med Chem; 2011 Aug 01; 19(15):4513-9. PubMed ID: 21741250
    [Abstract] [Full Text] [Related]

  • 27. Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination.
    Wang YT, Shi TQ, Fu J, Zhu HL.
    Eur J Med Chem; 2019 Jun 01; 171():209-220. PubMed ID: 30925337
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli beta-ketoacyl-ACP-synthase III (FabH).
    Alhamadsheh MM, Waters NC, Huddler DP, Kreishman-Deitrick M, Florova G, Reynolds KA.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):879-83. PubMed ID: 17189694
    [Abstract] [Full Text] [Related]

  • 29. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
    Qin YJ, Wang PF, Makawana JA, Wang ZC, Wang ZN, Yan-Gu, Jiang AQ, Zhu HL.
    Bioorg Med Chem Lett; 2014 Nov 15; 24(22):5279-83. PubMed ID: 25587588
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
    Sink R, Kovac A, Tomasić T, Rupnik V, Boniface A, Bostock J, Chopra I, Blanot D, Masic LP, Gobec S, Zega A.
    ChemMedChem; 2008 Sep 15; 3(9):1362-70. PubMed ID: 18651694
    [Abstract] [Full Text] [Related]

  • 31. QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.
    Singh S, Soni LK, Gupta MK, Prabhakar YS, Kaskhedikar SG.
    Eur J Med Chem; 2008 May 15; 43(5):1071-80. PubMed ID: 17707951
    [Abstract] [Full Text] [Related]

  • 32. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y, Yang YS, Song XD, Lu L, Zhu HL.
    Chem Pharm Bull (Tokyo); 2017 May 15; 65(2):178-185. PubMed ID: 28154310
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis and molecular docking of 1,4-benzodioxane thiazolidinedione piperazine derivatives as FabH inhibitors.
    Sun J, He W, Liu HY, Qin J, Ye CL.
    Bioorg Chem; 2019 Jul 15; 88():102958. PubMed ID: 31054434
    [Abstract] [Full Text] [Related]

  • 34. Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis.
    Wang ZC, Duan YT, Qin YJ, Wang PF, Luo Y, Wen Q, Yang YA, Sun J, Hu Y, Sang YL, Zhu HL.
    Eur J Med Chem; 2013 Jul 15; 65():456-63. PubMed ID: 23770447
    [Abstract] [Full Text] [Related]

  • 35. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Ashek A, Cho SJ.
    Bioorg Med Chem; 2006 Mar 01; 14(5):1474-82. PubMed ID: 16275103
    [Abstract] [Full Text] [Related]

  • 36. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
    Song H, Ao GZ, Li HQ.
    Expert Opin Ther Pat; 2014 Jan 01; 24(1):19-27. PubMed ID: 24083428
    [Abstract] [Full Text] [Related]

  • 37. A combine approach of chemical synthesis, biological evaluation and structural dynamics studies revealed thiazole substituted arylamine derivatives as potent FabH enzyme inhibitors.
    Ahmad H, Ahmad F, Parveen S, Ahmad S, Azam SS, Hassan A.
    Bioorg Chem; 2020 Dec 01; 105():104426. PubMed ID: 33161255
    [Abstract] [Full Text] [Related]

  • 38. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
    Liu JJ, Sun J, Fang YB, Yang YA, Jiao RH, Zhu HL.
    Org Biomol Chem; 2014 Feb 14; 12(6):998-1008. PubMed ID: 24382549
    [Abstract] [Full Text] [Related]

  • 39. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF, Yin Y, Qiao F, Wu X, Sha S, Zhang L, Zhu HL.
    Bioorg Med Chem; 2014 Apr 15; 22(8):2409-15. PubMed ID: 24680059
    [Abstract] [Full Text] [Related]

  • 40. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production.
    Misra N, Patra MC, Panda PK, Sukla LB, Mishra BK.
    J Biomol Struct Dyn; 2013 Mar 15; 31(3):241-57. PubMed ID: 22830394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.